Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Notes Payables Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Ani Pharmaceuticals (ANIP) Land & Improvements: 2012-2013

Ani Pharmaceuticals' Land & Improvements was N/A to $86,949 in Q3 2013 from the same period last year, while for Sep 2013 it was $86,949, marking a year-over-year change of. This contributed to the annual value of $86,949 for FY2012, which is N/A change from last year.
Per Ani Pharmaceuticals' latest filing, its Land & Improvements stood at $86,949 for Q3 2013, which was down 0.00% from $86,949 recorded in Q2 2013.
Ani Pharmaceuticals' Land & Improvements' 5-year high stood at $86,949 during Q4 2012, with a 5-year trough of $86,949 in Q4 2012.
Over the past 2 years, Ani Pharmaceuticals' median Land & Improvements value was $86,949 (recorded in 2013), while the average stood at $86,949.